Hezong Medicine Easy-To-Buy Pharmaceutical(300937.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Hezong Medicine Easy-To-Buy Pharmaceutical
300937.SZ
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. provides omni-channel pharmaceutical distribution services in China. It is involved in pharmaceutical B2B e-commerce, production, wholesale, and retail businesses, as well as provides logistics services. It offers Western medicine, Chinese patent medicine, Chinese herbal medicine slices and Chinese medicinal materials, food and health food, medical devices and non-pharmaceuticals, and other categories.
85.39 B
300937.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
Drug RetailIndustry
Industry Ranking8/8
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-2.36%D
    • Profit Margin-0.45%D
    • Gross Margin10.15%E
  • Growth ScoreC
    • Revenue YoY3.49%C
    • Net Profit YoY-274.57%E
    • Total Assets YoY8.66%B
    • Net Assets YoY-4.83%D
  • Cash ScoreD
    • Cash Flow Margin-139.44%E
    • OCF YoY3.49%C
  • Operating ScoreA
    • Turnover2.44A
  • Debt ScoreD
    • Gearing Ratio57.62%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pharmaceutical commercial stocks opened higher, with Yifeng Pharmacy hitting the daily limit, followed by DSL, Jointown, Hezong Medicine Easy-To-Buy Pharmaceutical, SYPM, and LBX. In terms of news, the Ministry of Commerce and 8 other departments issued the "Opinions on Promoting the High-Quality Development of the Pharmaceutical Retail Industry."

    Wallstreetcn·
    SZ
    300937
    +0.19%
    SZ
    301017
    +0.07%
    SH
    603233
    0.00%
    Wallstreetcn·
    SZ
    300937
    +0.19%
    SZ
    301017
    +0.07%
    SH
    603233
    0.00%

    A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin dropping over 18%. HRPC, DAJIAWEIKANG, INT'L GROUP, and Hezong Medicine Easy-To-Buy Pharmaceutical all fell more than 5%, while Huaren Health, CQP, and Kaikai Industry also followed suit

    Wallstreetcn·
    SZ
    000950
    +1.24%
    SZ
    301126
    +0.17%
    SH
    600829
    +0.87%
    Wallstreetcn·
    SZ
    000950
    +1.24%
    SZ
    301126
    +0.17%
    SH
    600829
    +0.87%

    Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 742,100 yuan in the third quarter, a decrease of 140.42%

    Zhitong·
    SZ
    300937
    +0.19%
    Zhitong·
    SZ
    300937
    +0.19%

    The pharmaceutical commercial sector experiences a surge, China Meheco hits the daily limit up

    Zhitong·
    SH
    600056
    +0.91%
    SZ
    301017
    +0.07%
    SH
    600272
    +0.24%
    Zhitong·
    SH
    600056
    +0.91%
    SZ
    301017
    +0.07%
    SH
    600272
    +0.24%

    Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 7.6144 million yuan in the first half of 2025

    Zhitong·
    SZ
    300937
    +0.19%
    Zhitong·
    SZ
    300937
    +0.19%
    © 2026 Longbridge｜Disclaimer